Hepatopulmonary syndrome (HPS) is a progressive, debilitating complication of end-stage liver disease. In contrast to the well-established reversal of HPS after deceased donor liver transplantation (DDLT), little has been written about the natural course of HPS after the newer procedure of living do
Liver transplantation and pancreatic resection: A single-center experience and a review of the literature
β Scribed by John A. Stauffer; Jeffery L. Steers; Hugo Bonatti; Marjorie K. Dougherty; Jaime Aranda-Michel; Rolland C. Dickson; Denise M. Harnois; Justin H. Nguyen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 104 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21932
No coin nor oath required. For personal study only.
β¦ Synopsis
Liver transplantation may occasionally be indicated in patients with unique clinical scenarios. Little is known regarding the outcomes of patients who have had a pancreatic resection prior to, in combination with, or after liver transplantation. A retrospective review of all patients undergoing liver transplantation from March 1998 to March 2008 identified 17 patients who also underwent pancreatic resection. An additional literature review was performed. Five underwent pancreatic resection prior to liver transplantation (1.7, 3.6, 3.8, 6.8, and 8.1 years), another 9 underwent pancreatic resection together with liver transplantation, and 3 underwent pancreatic resection after liver transplantation (2.2, 2.6, and 3.8 years). Indications for pancreatic resection included cholangiocarcinoma (n Ο 6), neuroendocrine tumor (n Ο 5), pancreatic cancer (n Ο 2), gastrointestinal stromal tumor (n Ο 1), periampullary adenocarcinoma (n Ο 1), duodenal adenomas (n Ο 1), and benign pancreatic mass (n Ο 1). Indications for liver transplantation were metastatic neuroendocrine tumor disease (n Ο 5), primary sclerosing cholangitis (n Ο 5), hepatitis C virus (n Ο 2), metastatic gastrointestinal stromal tumor (n Ο 1), Klatskin tumor (n Ο 1), alcohol cirrhosis (n Ο 1), alpha-1 antitrypsin deficiency (n Ο 1), and chemotherapy-induced cirrhosis (n Ο 1). One patient died intraoperatively, 7 patients died of tumor recurrence, 2 patients died from transplant complications, and 7 patients are still alive. Pancreatic resection-related complications included 4 pancreatic fistulas. A literature review confirmed liver transplantation/pancreatic resection-related complications. In conclusion, liver transplantation and pancreatic resection remain uncommon, and a good outcome can be achieved. Recurrence of malignant disease is the main factor limiting survival, and specific morbidity may be related to pancreatic resection and liver transplantation.
π SIMILAR VOLUMES
Liver transplantation (LT) is the only curative option for patients with familial amyloid polyneuropathy (FAP) at present. Twenty patients with FAP underwent LT between May 1998 and June 2007. Transthyretin mutations included predominantly the Val30Met mutation but also 10 other mutations. Seven pat
## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the doseβlimiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The
Over the past 4 decades, the surgical techniques of liver transplantation (LTx) have permanently evolved and been modified. Among these, the modified piggyback (MPB) technique by Belghiti offers specific advantages. The objective of this study was to present our single-center experience with the MPB
Infertility is common in women with end-stage liver disease. Successful liver transplant (LT), however, can restore childbearing potential. Controversy exists regarding the most appropriate immunosuppressive regimen and timing of conception following LT. We report the outcomes of a review of all pre